\-\ Texto\\:\\ \ \(0\)\
\-\ neurologic\\ exam\\:\ \(0\)\
\-\ mental\\ status\\:\\ alert\\ and\\ oriented\\ to\\ person\\,\\ place\\,\\ time\\.\\ \\ \ \(0\)\
\-\ cranial\\ nerves\\:\\ \ \(0\)\
\-\ ii\\:\\ vfftc\\,\\ perrl\\,\\ os\\:\\ indistinct\\ disc\\ margins\\ od\\:\\ indistinct\\ disc\\ margins\ \(0\)\
\-\ iii\\,iv\\,vi\\:\\ eomi\\,\\ smooth\\ pursuits\\,\\ hypometric\\ horizontal\\ and\\ vertical\\ saccades\\.\\ no\\ primary\\ or\\ gaze\\-evoked\\ nystagmus\\.\ \(0\)\
\-\ v\\:\\ momi\\,\\ sensation\\ intact\\ lt\\/pp\\ v1\\/v2\\/v3\\.\ \(0\)\
\-\ vii\\:\\ symmetric\\ muscles\\ of\\ facial\\ expression\\ in\\ upper\\/lower\ \(0\)\
\-\ viii\\:\\ hearing\\ intact\\ to\\ conversation\\.\\ \\ \ \(0\)\
\-\ ix\\,x\\:\\ symmetric\\ volitional\\ palate\\/uvula\\ rise\\,\\ no\\ hypophonia\\,\\ dysphonia\\,\\ no\\ dysarthria\\,\\ no\\ hoarseness\\.\\ \ \(0\)\
\-\ xi\\:\\ 5\\/5\\ scm\\ and\\ trapezius\\ strength\ \(0\)\
\-\ xii\\:\\ tongue\\ midline\\ on\\ protrusion\\,\\ no\\ fasciculations\\ or\\ atrophy\\.\ \(0\)\
\-\ motor\\:\\ normal\\ bulk\\ and\\ tone\\.\\ no\\ fasciculations\\,\\ mild\\ tremor\\ in\\ hands\\ l\\>r\\.\\ no\\ pronator\\ drift\\.\ \(0\)\
\-\ rue\\:\\ 5\\/5\\ deltoid\\,\\ biceps\\,\\ triceps\\,\\ wrist\\ flexion\\,\\ wrist\\ extension\\,\\ finger\\ flexion\\,\\ interossei\\ \ \(0\)\
\-\ lue\\:\\ 5\\/5\\ deltoid\\,\\ biceps\\,\\ triceps\\,\\ wrist\\ flexion\\,\\ wrist\\ extension\\,\\ finger\\ flexion\\,\\ interossei\\ \ \(0\)\
\-\ rle\\:\\ 3\\/5\\ hip\\ flexion\\,\\ hip\\ ab\\/adduction\\,\\ knee\\ flexion\\/extension\\,\\ 3\\/5\\ dorsiflexion\\,\\ 4\\/5\\ plantarflexion\ \(0\)\
\-\ lle\\:\\ 2\\/5\\ hip\\ flexion\\,\\ hip\\ ab\\/adduction\\,\\ knee\\ extension\\,\\ 3\\/5\\ knee\\ flexion\\,\\ dorsiflexion\\,\\ plantarflexion\ \(0\)\
\-\ sensory\\:\\ intact\\ and\\ symmetric\\ to\\ light\\ touch\\,\\ temperature\\,\\ and\\ vibration\\ in\\ the\\ upper\\ extremities\\.\\ \\ decreased\\ light\\ touch\\,\\ temperature\\ l\\>r\\ bilateral\\ feet\\ and\\ medial\\ legs\\.\\ mildly\\ decreased\\ vibratory\\ sensation\\ bilateral\\ lower\\ extremities\\.\\ \\ \\ \ \(0\)\
\-\ reflexes\\:\ \(1\)\
\-\ right\\:\\ biceps\\ 1\\/4\\,\\ triceps\\ 1\\/4\\,\\ br\\ 1\\/4\\,\\ patellar\\ 0\\/4\\,\\ achilles\\ 0\\/4\\,\\ plantar\\ up\ \(0\)\
\-\ left\\:\\ biceps\\ 2\\/4\\,\\ triceps\\ 2\\/4\\,\\ br\\ 2\\/4\\,\\ patellar\\ 0\\/4\\,\\ achilles\\ 0\\/4\\,\\ plantar\\ up\ \(0\)\
\-\ coordination\\:\\ finger\\-nose\\-finger\\,\\ finger\\ tapping\\ within\\ normal\\ limits\\ with\\ mild\\ end\\-point\\ tremor\\.\\ heel\\-shin\\ normal\\.\ \(0\)\
\-\ gait\\:\\ deferred\\ due\\ to\\ weakness\ \(0\)\
\-\ labs\\ unremarkable\ \(4\)\
\-\ infliximab\\ induction\\ therapy\\ and\\ maintenance\ \(0\)\
\-\ mri\\ of\\ the\\ lumbar\\ spine\\ with\\ and\\ without\\ contrast\\:\\ \ \(0\)\
\-\ comparison\\:\\ mri\\ lumbar\\ spine\\ dated\\ 5\\/14\\/2015\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ findings\\:\\ there\\ are\\ 5\\ non\\-rib\\ bearing\\ lumbar\\ type\\ vertebral\\ bodies\\.\\ \\ the\\ \ \(0\)\
\-\ vertebral\\ body\\ heights\\ and\\ alignment\\ are\\ maintained\\.\\ disc\\ desiccation\\ is\\ noted\\ \ \(0\)\
\-\ from\\ l2\\ to\\ s1\\,\\ with\\ partial\\ disc\\ height\\ loss\\ at\\ l5\\-s1\\.\\ fatty\\ degenerative\\ \ \(0\)\
\-\ endplate\\ changes\\ are\\ again\\ seen\\ at\\ l5\\-s1\\.\\ the\\ bone\\ marrow\\ signal\\ is\\ otherwise\\ \ \(0\)\
\-\ normal\\.\\ no\\ significant\\ spinal\\ canal\\ or\\ neural\\ foraminal\\ narrowing\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ the\\ conus\\ medullaris\\ terminates\\ in\\ a\\ normal\\ location\\ at\\ the\\ level\\ of\\ l2\\.\\ there\\ \ \(0\)\
\-\ is\\ increased\\ enhancement\\ and\\ thickening\\ of\\ the\\ nerve\\ roots\\ of\\ the\\ cauda\\ equina\\ with\\ increased\\ meningeal\\ enhancement\\ about\\ the\\ conus\\ medullaris\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ partially\\ visualized\\ sacroiliac\\ joints\\ are\\ unremarkable\\.\\ \\ paraspinal\\ soft\\ \ \(0\)\
\-\ tissues\\ are\\ unremarkable\\.\ \(11\)\
\-\ \\ \ \(1082074\)\
\-\ impression\\:\\ \\ \ \(0\)\
\-\ interval\\ worsening\\ of\\ diffuse\\ leptomeningeal\\ enhancement\\ around\\ the\\ conus\\ \ \(0\)\
\-\ medullaris\\ and\\ cauda\\ equina\\ \\(thickened\\)\\,\\ compatible\\ with\\ progression\\ of\\ \ \(1\)\
\-\ neurosarcoidosis\\.\ \(1\)\
\-\ spinal\\ leptomeningeal\\ neurosarcoidosis\\ of\\ the\\ conus\\ medullaris\ \(0\)\
\-\ 1\\.\\ neurosarcoidosis\ \(0\)\
\-\ 2\\.\\ tuberculous\\ meningitis\ \(0\)\
\-\ 3\\.\\ leptomenigeal\\ carcinomatosis\ \(0\)\
\-\ 4\\.\\ chronic\\ inflammatory\\ demyelinating\\ polyneuropathy\ \(0\)\
\-\ 5\\.\\ lymphoma\ \(0\)\
\-\ 54\\ yo\\ lhd\\ woman\\ presents\\ with\\ progressively\\ increasing\\ weakness\\ of\\ her\\ bilateral\\ lower\\ extremities\\ l\\>r\\.\\ her\\ neurologic\\ symptoms\\ began\\ in\\ 2009\\.\\ she\\ noticed\\ that\\ she\\ was\\ tripping\\ and\\ falling\\ frequently\\,\\ and\\ it\\ felt\\ as\\ if\\ she\\ was\\ not\\ lifting\\ her\\ legs\\ up\\ high\\ enough\\.\\ in\\ march\\ 2009\\,\\ she\\ had\\ an\\ mri\\ due\\ to\\ chronic\\ lower\\ back\\ pain\\,\\ at\\ that\\ time\\ an\\ intramedullary\\ lesion\\ at\\ l1\\ and\\ and\\ extramedullary\\ lesion\\ at\\ the\\ conus\\ medullaris\\ were\\ noted\\.\\ \ \(0\)\
\-\ other\\ symptoms\\ included\\ cough\\ and\\ shortness\\ of\\ breath\\.\\ she\\ was\\ subsequently\\ diagnosed\\ with\\ sarcoidosis\\ by\\ mediastinal\\ lymph\\ node\\ biopsy\\ in\\ 2009\\.\\ she\\ was\\ placed\\ on\\ oral\\ prednisone\\ for\\ 7\\ months\\ with\\ minimal\\ relief\\ of\\ symptoms\\.\\ in\\ 2011\\,\\ she\\ had\\ a\\ steroid\\ infusion\\ followed\\ by\\ methotrexate\\ maintenance\\ which\\ she\\ says\\ helped\\ her\\ symptoms\\ for\\ several\\ months\\.\\ her\\ most\\ recent\\ infusion\\ was\\ in\\ 2014\\,\\ but\\ she\\ only\\ had\\ a\\ 4\\ week\\ improvement\\ of\\ symptoms\\.\\ \\ \ \(0\)\
\-\ over\\ the\\ past\\ 2\\ months\\,\\ the\\ patient\\ notes\\ progressive\\ weakness\\.\\ her\\ left\\ leg\\ is\\ more\\ affected\\ than\\ her\\ right\\ leg\\.\\ pt\\ began\\ falling\\ frequently\\ and\\ is\\ no\\ longer\\ able\\ to\\ ambulate\\ without\\ assistance\\,\\ she\\ now\\ uses\\ a\\ wheelchair\\.\\ the\\ patient\\ also\\ notes\\ decreased\\ sensation\\ in\\ both\\ feet\\ as\\ well\\ as\\ decreased\\ sensation\\ in\\ both\\ lateral\\ legs\\.\\ the\\ patient\\ also\\ has\\ neuropathic\\ pain\\ in\\ the\\ legs\\ for\\ which\\ she\\ takes\\ neurontin\\.\\ she\\ reports\\ occasional\\ urge\\ sensations\\ in\\ her\\ bladder\\,\\ but\\ denies\\ incontinence\\ of\\ bladder\\ or\\ bowel\\.\\ at\\ times\\ she\\ does\\ experience\\ urinary\\ retention\\.\\ pt\\ also\\ endorses\\ difficulty\\ with\\ writing\\,\\ with\\ her\\ hands\\ \\"more\\ shaky\\"\\ than\\ usual\\ over\\ these\\ past\\ 2\\ months\\.\\ she\\ also\\ has\\ once\\ weekly\\ headaches\\,\\ but\\ denies\\ any\\ associated\\ neurologic\\ symptoms\\.\ \(0\)\
\-\ neurologic\\ complications\\ of\\ sarcoidosis\\ occur\\ in\\ 5\\ to\\ 10\\ percent\\ of\\ patients\\ with\\ sarcoidosis\\.\\ it\\ was\\ helpful\\ in\\ this\\ case\\ that\\ the\\ patient\\ previously\\ carried\\ this\\ diagnosis\\.\\ any\\ portion\\ of\\ the\\ peripheral\\ or\\ central\\ nervous\\ system\\ can\\ be\\ affected\\ by\\ sarcoidosis\\.\\ it\\ is\\ important\\ in\\ patients\\ who\\ present\\ with\\ this\\ to\\ have\\ a\\ full\\ evaluation\\ to\\ rule\\-out\\ infectious\\ or\\ malignant\\ causes\\.\\ the\\ gold\\ standard\\ for\\ diagnosis\\ of\\ sarcoidosis\\ is\\ biopsy\\.\\ extraneural\\ tissue\\ biopsy\\ is\\ preferred\\ if\\ other\\ organ\\ systems\\ are\\ involved\\.\\ corticosteroids\\ are\\ the\\ first\\ line\\ treatment\\ in\\ these\\ patients\\,\\ however\\ other\\ immunomodulating\\ therapies\\ may\\ be\\ considered\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ she\\:\\ 0\\.2516722393246256\ \(0\)\
\-\ flexion\\:\\ 0\\.2052304639946729\ \(0\)\
\-\ medullaris\\:\\ 0\\.1779998318079364\ \(0\)\
\-\ her\\:\\ 0\\.16979811875541778\ \(0\)\
\-\ conus\\:\\ 0\\.16217517310541119\ \(0\)\
\-\ neurosarcoidosis\\:\\ 0\\.1448830631396518\ \(0\)\
\-\ finger\\:\\ 0\\.14349884546414943\ \(0\)\
\-\ in\\:\\ 0\\.13522438143346974\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.1279039327603464\ \(0\)\
\-\ the\\:\\ 0\\.12654058676531024\ \(0\)\
\-\ triceps\\:\\ 0\\.12418434326163176\ \(0\)\
\-\ biceps\\:\\ 0\\.12115405640043729\ \(0\)\
\-\ legs\\:\\ 0\\.11881733874532134\ \(0\)\
\-\ and\\:\\ 0\\.11232358617255457\ \(0\)\
\-\ disc\\:\\ 0\\.10494459819118374\ \(0\)\
\-\ wrist\\:\\ 0\\.10429795606984525\ \(0\)\
\-\ sensation\\:\\ 0\\.1035164694541513\ \(0\)\
\-\ of\\:\\ 0\\.10046590503969222\ \(0\)\
\-\ symptoms\\:\\ 0\\.0991382285962424\ \(0\)\
\-\ 2009\\:\\ 0\\.0977071990864675\ \(0\)\
\-\ neurologic\\:\\ 0\\.09652330981034489\ \(0\)\
\-\ hip\\:\\ 0\\.09279155510840824\ \(0\)\
\-\ interossei\\:\\ 0\\.09229566771782205\ \(0\)\
\-\ no\\:\\ 0\\.08838257017072955\ \(0\)\
\-\ fasciculations\\:\\ 0\\.08688707564848927\ \(0\)\
\-\ extension\\:\\ 0\\.08550852656474289\ \(0\)\
\-\ plantarflexion\\:\\ 0\\.08332452712728623\ \(0\)\
\-\ are\\:\\ 0\\.08021333021768752\ \(0\)\
\-\ at\\:\\ 0\\.07984511628885466\ \(0\)\
\-\ s1\\:\\ 0\\.07908215795560468\ \(0\)\
\-\ symmetric\\:\\ 0\\.07763735209061347\ \(0\)\
\-\ dorsiflexion\\:\\ 0\\.07598552499184463\ \(0\)\
\-\ to\\:\\ 0\\.07549624873182759\ \(0\)\
\-\ maintenance\\:\\ 0\\.07525503247110185\ \(0\)\
\-\ decreased\\:\\ 0\\.07482287007856442\ \(0\)\
\-\ br\\:\\ 0\\.07392981237473505\ \(0\)\
\-\ tremor\\:\\ 0\\.07332462240499302\ \(0\)\
\-\ lumbar\\:\\ 0\\.0731549605990572\ \(0\)\
\-\ with\\:\\ 0\\.0709594823957744\ \(0\)\
\-\ equina\\:\\ 0\\.07072928003990468\ \(0\)\
\-\ months\\:\\ 0\\.07031243201219119\ \(0\)\
\-\ cauda\\:\\ 0\\.07027866131149725\ \(0\)\
\-\ notes\\:\\ 0\\.06984644040176907\ \(0\)\
\-\ indistinct\\:\\ 0\\.06943117376625749\ \(0\)\
\-\ deltoid\\:\\ 0\\.06943117376625749\ \(0\)\
\-\ infusion\\:\\ 0\\.06943117376625749\ \(0\)\
\-\ extremities\\:\\ 0\\.06884853589400318\ \(0\)\
\-\ is\\:\\ 0\\.06616103387987318\ \(0\)\
\-\ weakness\\:\\ 0\\.06611922506810737\ \(0\)\
\-\ intact\\:\\ 0\\.06557151862077305\ \(0\)\
\-\ knee\\:\\ 0\\.06493826877272503\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.06386093058773296\ \(0\)\
\-\ biopsy\\:\\ 0\\.06350471311219862\ \(0\)\
\-\ was\\:\\ 0\\.06314735247582011\ \(0\)\
\-\ or\\:\\ 0\\.0630336167531004\ \(0\)\
\-\ l2\\:\\ 0\\.06209217163081588\ \(0\)\
\-\ lower\\:\\ 0\\.06172634992829954\ \(0\)\
\-\ plantar\\:\\ 0\\.061692579227605605\ \(0\)\
\-\ normal\\:\\ 0\\.061649708662508476\ \(0\)\
\-\ temperature\\:\\ 0\\.06149829961189596\ \(0\)\
\-\ falling\\:\\ 0\\.06149829961189596\ \(0\)\
\-\ unremarkable\\:\\ 0\\.06073564779000402\ \(0\)\
\-\ touch\\:\\ 0\\.05925180810385184\ \(0\)\
\-\ achilles\\:\\ 0\\.05894488974512443\ \(0\)\
\-\ patellar\\:\\ 0\\.058214397224381646\ \(0\)\
\-\ hands\\:\\ 0\\.05726962315713633\ \(0\)\
\-\ also\\:\\ 0\\.056818481207673355\ \(0\)\
\-\ feet\\:\\ 0\\.05676534013753769\ \(0\)\
\-\ began\\:\\ 0\\.05616699213377584\ \(0\)\
\-\ light\\:\\ 0\\.05230940446746205\ \(0\)\
\-\ enhancement\\:\\ 0\\.05214560156522505\ \(0\)\
\-\ margins\\:\\ 0\\.05153052827385977\ \(0\)\
\-\ patients\\:\\ 0\\.050965323004157674\ \(0\)\
\-\ frequently\\:\\ 0\\.049738689325273096\ \(0\)\
\-\ affected\\:\\ 0\\.049675477543574\ \(0\)\
\-\ denies\\:\\ 0\\.048712273633579876\ \(0\)\
\-\ bilateral\\:\\ 0\\.048689746510091066\ \(0\)\
\-\ as\\:\\ 0\\.04852761730105018\ \(0\)\
\-\ hypometric\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ momi\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ volitional\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ tapping\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ lhd\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ urge\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ shaky\\:\\ 0\\.048294354379883934\ \(0\)\
\-\ other\\:\\ 0\\.04704806652705718\ \(0\)\
\-\ bladder\\:\\ 0\\.04686853206219274\ \(0\)\
\-\ mri\\:\\ 0\\.04650405576263938\ \(0\)\
\-\ it\\:\\ 0\\.046374933807678424\ \(0\)\
\-\ hypophonia\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ dysphonia\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ leptomenigeal\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ neurontin\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ extraneural\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ immunomodulating\\:\\ 0\\.046147833858911025\ \(0\)\
\-\ vertebral\\:\\ 0\\.04612193620452698\ \(0\)\
\-\ leg\\:\\ 0\\.04559462680933549\ \(0\)\
\-\ had\\:\\ 0\\.04513836295278885\ \(0\)\
\-\ up\\:\\ 0\\.04481453145067117\ \(0\)\
\-\ but\\:\\ 0\\.044799967567964394\ \(0\)\
\-\ vfftc\\:\\ 0\\.044624853312163135\ \(0\)\
\-\ pursuits\\:\\ 0\\.044624853312163135\ \(0\)\
\-\ pt\\:\\ 0\\.04346604092067052\ \(0\)\
\-\ saccades\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ conversation\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ scm\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ vibration\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ vibratory\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ infliximab\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ dated\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ tripping\\:\\ 0\\.043443537824244635\ \(0\)\
\-\ spinal\\:\\ 0\\.042886201961440204\ \(0\)\
\-\ xi\\:\\ 0\\.042478332791190225\ \(0\)\
\-\ lue\\:\\ 0\\.042478332791190225\ \(0\)\
\-\ ix\\:\\ 0\\.041662263563643116\ \(0\)\
\-\ carried\\:\\ 0\\.041662263563643116\ \(0\)\
\-\ this\\:\\ 0\\.04150731915597693\ \(0\)\
\-\ bulk\\:\\ 0\\.040955352244442335\ \(0\)\
\-\ rue\\:\\ 0\\.040955352244442335\ \(0\)\
\-\ deferred\\:\\ 0\\.040955352244442335\ \(0\)\
\-\ wheelchair\\:\\ 0\\.040955352244442335\ \(0\)\
\-\ sensations\\:\\ 0\\.040955352244442335\ \(0\)\
\-\ induction\\:\\ 0\\.04033181227021731\ \(0\)\
\-\ heights\\:\\ 0\\.04033181227021731\ \(0\)\
\-\ writing\\:\\ 0\\.04033181227021731\ \(0\)\
\-\ spine\\:\\ 0\\.03989848509647234\ \(0\)\
\-\ rle\\:\\ 0\\.039774036756523835\ \(0\)\
\-\ terminates\\:\\ 0\\.039774036756523835\ \(0\)\
\-\ that\\:\\ 0\\.03931535777603381\ \(0\)\
\-\ past\\:\\ 0\\.039314174530037466\ \(0\)\
\-\ patient\\:\\ 0\\.0392885322419815\ \(0\)\
\-\ expression\\:\\ 0\\.03926946742930808\ \(0\)\
\-\ pronator\\:\\ 0\\.03926946742930808\ \(0\)\
\-\ any\\:\\ 0\\.039033682842572776\ \(0\)\
\-\ viii\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ trapezius\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ drift\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ lle\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ desiccation\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ assistance\\:\\ 0\\.038808831723469425\ \(0\)\
\-\ by\\:\\ 0\\.03847240524230773\ \(0\)\
\-\ endorses\\:\\ 0\\.03838508795084954\ \(0\)\
\-\ says\\:\\ 0\\.037627516235550926\ \(0\)\
\-\ ambulate\\:\\ 0\\.037285851176721535\ \(0\)\
\-\ perrl\\:\\ 0\\.03696490618736752\ \(0\)\
\-\ helped\\:\\ 0\\.03696490618736752\ \(0\)\
\-\ weekly\\:\\ 0\\.03696490618736752\ \(0\)\
\-\ for\\:\\ 0\\.03661202139779022\ \(0\)\
\-\ dysarthria\\:\\ 0\\.036376080901422934\ \(0\)\
\-\ coordination\\:\\ 0\\.036376080901422934\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.036376080901422934\ \(0\)\
\-\ uses\\:\\ 0\\.036376080901422934\ \(0\)\
\-\ endplate\\:\\ 0\\.036104535688803036\ \(0\)\
\-\ tuberculous\\:\\ 0\\.036104535688803036\ \(0\)\
\-\ chronic\\:\\ 0\\.035850214076279904\ \(0\)\
\-\ time\\:\\ 0\\.03579910564887328\ \(0\)\
\-\ vii\\:\\ 0\\.03559996636158728\ \(0\)\
\-\ hoarseness\\:\\ 0\\.03536464001995234\ \(0\)\
\-\ neuropathic\\:\\ 0\\.03536464001995234\ \(0\)\
\-\ retention\\:\\ 0\\.03536464001995234\ \(0\)\
\-\ therapies\\:\\ 0\\.03536464001995234\ \(0\)\
\-\ od\\:\\ 0\\.035139330655748625\ \(0\)\
\-\ sacroiliac\\:\\ 0\\.035139330655748625\ \(0\)\
\-\ nervous\\:\\ 0\\.035139330655748625\ \(0\)\
\-\ if\\:\\ 0\\.035092433030158736\ \(0\)\
\-\ due\\:\\ 0\\.03471759948035545\ \(0\)\
\-\ 2014\\:\\ 0\\.03471558688312874\ \(0\)\
\-\ vi\\:\\ 0\\.0345157906815236\ \(0\)\
\-\ rise\\:\\ 0\\.03432326142820152\ \(0\)\
\-\ march\\:\\ 0\\.03432326142820152\ \(0\)\
\-\ gold\\:\\ 0\\.03432326142820152\ \(0\)\
\-\ mild\\:\\ 0\\.034237610575040676\ \(0\)\
\-\ than\\:\\ 0\\.034237610575040676\ \(0\)\
\-\ person\\:\\ 0\\.03413748899901675\ \(0\)\
\-\ these\\:\\ 0\\.03410644375250486\ \(0\)\
\-\ meningeal\\:\\ 0\\.033958015167830126\ \(0\)\
\-\ extramedullary\\:\\ 0\\.033958015167830126\ \(0\)\
\-\ methotrexate\\:\\ 0\\.033958015167830126\ \(0\)\
\-\ lifting\\:\\ 0\\.03378442679694165\ \(0\)\
\-\ both\\:\\ 0\\.03368059780461818\ \(0\)\
\-\ nystagmus\\:\\ 0\\.033616350109000735\ \(0\)\
\-\ over\\:\\ 0\\.03358365063428925\ \(0\)\
\-\ maintained\\:\\ 0\\.03345344584061437\ \(0\)\
\-\ more\\:\\ 0\\.03316467293077276\ \(0\)\
\-\ demyelinating\\:\\ 0\\.03314194594028302\ \(0\)\
\-\ intramedullary\\:\\ 0\\.03314194594028302\ \(0\)\
\-\ eomi\\:\\ 0\\.03284776076018759\ \(0\)\
\-\ takes\\:\\ 0\\.03284776076018759\ \(0\)\
\-\ horizontal\\:\\ 0\\.032706579833702135\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.032706579833702135\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.032706579833702135\ \(0\)\
\-\ increased\\:\\ 0\\.032660081741429904\ \(0\)\
\-\ tongue\\:\\ 0\\.03256906636215583\ \(0\)\
\-\ l1\\:\\ 0\\.03256906636215583\ \(0\)\
\-\ 2011\\:\\ 0\\.03256906636215583\ \(0\)\
\-\ alignment\\:\\ 0\\.032435034621082236\ \(0\)\
\-\ upper\\:\\ 0\\.03227547448638875\ \(0\)\
\-\ enough\\:\\ 0\\.0321767409072286\ \(0\)\
\-\ os\\:\\ 0\\.03205217113648964\ \(0\)\
\-\ xii\\:\\ 0\\.03205217113648964\ \(0\)\
\-\ roots\\:\\ 0\\.03205217113648964\ \(0\)\
\-\ preferred\\:\\ 0\\.03205217113648964\ \(0\)\
\-\ noted\\:\\ 0\\.03202265203463472\ \(0\)\
\-\ incontinence\\:\\ 0\\.03193046529386648\ \(0\)\
\-\ without\\:\\ 0\\.031857396519625734\ \(0\)\
\-\ prednisone\\:\\ 0\\.03181149464685721\ \(0\)\
\-\ vertical\\:\\ 0\\.03169513895223154\ \(0\)\
\-\ foraminal\\:\\ 0\\.03169513895223154\ \(0\)\
\-\ usual\\:\\ 0\\.03136067167968149\ \(0\)\
\-\ diagnosis\\:\\ 0\\.031309622200487\ \(0\)\
\-\ protrusion\\:\\ 0\\.03114888459867381\ \(0\)\
\-\ organ\\:\\ 0\\.03104608581540794\ \(0\)\
\-\ longer\\:\\ 0\\.03074914980594798\ \(0\)\
\-\ case\\:\\ 0\\.030343033939501652\ \(0\)\
\-\ compatible\\:\\ 0\\.03020100845504611\ \(0\)\
\-\ experience\\:\\ 0\\.030030220386255687\ \(0\)\
\-\ tone\\:\\ 0\\.029946849041279935\ \(0\)\
\-\ noticed\\:\\ 0\\.029946849041279935\ \(0\)\
\-\ percent\\:\\ 0\\.02986477032748944\ \(0\)\
\-\ bearing\\:\\ 0\\.029704334686330335\ \(0\)\
\-\ progressively\\:\\ 0\\.029548618431258625\ \(0\)\
\-\ paraspinal\\:\\ 0\\.02939735182636939\ \(0\)\
\-\ impression\\:\\ 0\\.02939735182636939\ \(0\)\
\-\ systems\\:\\ 0\\.02917825969246679\ \(0\)\
\-\ steroid\\:\\ 0\\.029107198612190823\ \(0\)\
\-\ occasional\\:\\ 0\\.029107198612190823\ \(0\)\
\-\ height\\:\\ 0\\.028967875545346456\ \(0\)\
\-\ lesion\\:\\ 0\\.028955892395401972\ \(0\)\
\-\ comparison\\:\\ 0\\.028765533553361436\ \(0\)\
\-\ fatty\\:\\ 0\\.02869976909282989\ \(0\)\
\-\ helpful\\:\\ 0\\.028634811578568165\ \(0\)\
\-\ atrophy\\:\\ 0\\.028570641447514995\ \(0\)\
\-\ sensory\\:\\ 0\\.02844458856400742\ \(0\)\
\-\ meningitis\\:\\ 0\\.02844458856400742\ \(0\)\
\-\ 54\\:\\ 0\\.02844458856400742\ \(0\)\
\-\ once\\:\\ 0\\.028382670068768844\ \(0\)\
\-\ relief\\:\\ 0\\.028321467410323046\ \(0\)\
\-\ nerves\\:\\ 0\\.028201144708398258\ \(0\)\
\-\ standard\\:\\ 0\\.028025637884510738\ \(0\)\
\-\ neural\\:\\ 0\\.027968405208247938\ \(0\)\
\-\ alert\\:\\ 0\\.027800328520307026\ \(0\)\
\-\ progression\\:\\ 0\\.02769117061196069\ \(0\)\
\-\ has\\:\\ 0\\.02758780607859719\ \(0\)\
\-\ which\\:\\ 0\\.027463332145540885\ \(0\)\
\-\ hearing\\:\\ 0\\.027427734623790227\ \(0\)\
\-\ interval\\:\\ 0\\.0273259243515893\ \(0\)\
\-\ oriented\\:\\ 0\\.027226035143001204\ \(0\)\
\-\ place\\:\\ 0\\.027226035143001204\ \(0\)\
\-\ times\\:\\ 0\\.027176788546082\ \(0\)\
\-\ again\\:\\ 0\\.026937201462975267\ \(0\)\
\-\ felt\\:\\ 0\\.02653150738732531\ \(0\)\
\-\ able\\:\\ 0\\.026488291057595252\ \(0\)\
\-\ bodies\\:\\ 0\\.02644542466150005\ \(0\)\
\-\ reflexes\\:\\ 0\\.026402902577524437\ \(0\)\
\-\ improvement\\:\\ 0\\.026360719318534894\ \(0\)\
\-\ mental\\:\\ 0\\.026318869527530268\ \(0\)\
\-\ gait\\:\\ 0\\.026154702233731026\ \(0\)\
\-\ included\\:\\ 0\\.026114443705172765\ \(0\)\
\-\ urinary\\:\\ 0\\.026114443705172765\ \(0\)\
\-\ iii\\:\\ 0\\.026074489017461313\ \(0\)\
\-\ joints\\:\\ 0\\.02595640298420512\ \(0\)\
\-\ node\\:\\ 0\\.02595640298420512\ \(0\)\
\-\ partially\\:\\ 0\\.02591761914046459\ \(0\)\
\-\ muscles\\:\\ 0\\.025879117363537825\ \(0\)\
\-\ subsequently\\:\\ 0\\.025765264136929884\ \(0\)\
\-\ degenerative\\:\\ 0\\.025653807999334113\ \(0\)\
\-\ important\\:\\ 0\\.02558078655206928\ \(0\)\
\-\ thickened\\:\\ 0\\.02547310885371245\ \(0\)\
\-\ difficulty\\:\\ 0\\.02540252152805606\ \(0\)\
\-\ strength\\:\\ 0\\.025298374477625656\ \(0\)\
\-\ marrow\\:\\ 0\\.025096032485640636\ \(0\)\
\-\ smooth\\:\\ 0\\.024933128217254272\ \(0\)\
\-\ facial\\:\\ 0\\.024901140379794195\ \(0\)\
\-\ cranial\\:\\ 0\\.024682479228184576\ \(0\)\
\-\ be\\:\\ 0\\.024500840455898218\ \(0\)\
\-\ mildly\\:\\ 0\\.024384986866352397\ \(0\)\
\-\ mediastinal\\:\\ 0\\.024384986866352397\ \(0\)\
\-\ infectious\\:\\ 0\\.024298904140527138\ \(0\)\
\-\ previously\\:\\ 0\\.024242283590181993\ \(0\)\
\-\ shortness\\:\\ 0\\.02421419879756198\ \(0\)\
\-\ involved\\:\\ 0\\.02421419879756198\ \(0\)\
\-\ oral\\:\\ 0\\.02418626221034204\ \(0\)\
\-\ around\\:\\ 0\\.02410332624272521\ \(0\)\
\-\ there\\:\\ 0\\.024031967280043205\ \(0\)\
\-\ motor\\:\\ 0\\.02402166954423989\ \(0\)\
\-\ limits\\:\\ 0\\.023862040234815335\ \(0\)\
\-\ ii\\:\\ 0\\.023809882463232207\ \(0\)\
\-\ tissues\\:\\ 0\\.023809882463232207\ \(0\)\
\-\ increasing\\:\\ 0\\.023783995022928866\ \(0\)\
\-\ full\\:\\ 0\\.02360624308832367\ \(0\)\
\-\ visualized\\:\\ 0\\.02358133023767568\ \(0\)\
\-\ placed\\:\\ 0\\.023531853513129544\ \(0\)\
\-\ line\\:\\ 0\\.023531853513129544\ \(0\)\
\-\ considered\\:\\ 0\\.023531853513129544\ \(0\)\
\-\ lymph\\:\\ 0\\.02348283491298003\ \(0\)\
\-\ reports\\:\\ 0\\.02348283491298003\ \(0\)\
\-\ narrowing\\:\\ 0\\.02341014767050638\ \(0\)\
\-\ partial\\:\\ 0\\.023267700395254467\ \(0\)\
\-\ canal\\:\\ 0\\.023244327416922114\ \(0\)\
\-\ progressive\\:\\ 0\\.02312898579585436\ \(0\)\
\-\ complications\\:\\ 0\\.02312898579585436\ \(0\)\
\-\ an\\:\\ 0\\.023095791143770673\ \(0\)\
\-\ worsening\\:\\ 0\\.02306096810226349\ \(0\)\
\-\ minimal\\:\\ 0\\.023038488361509516\ \(0\)\
\-\ system\\:\\ 0\\.023038488361509516\ \(0\)\
\-\ causes\\:\\ 0\\.022818789989874452\ \(0\)\
\-\ midline\\:\\ 0\\.022712267864999518\ \(0\)\
\-\ about\\:\\ 0\\.02260784690583834\ \(0\)\
\-\ cough\\:\\ 0\\.02254616887622597\ \(0\)\
\-\ headaches\\:\\ 0\\.022525768192047844\ \(0\)\
\-\ occur\\:\\ 0\\.022209616295817025\ \(0\)\
\-\ breath\\:\\ 0\\.022133442737120614\ \(0\)\
\-\ diagnosed\\:\\ 0\\.02187514902326698\ \(0\)\
\-\ pain\\:\\ 0\\.021612438739194408\ \(0\)\
\-\ portion\\:\\ 0\\.021594608105860752\ \(0\)\
\-\ peripheral\\:\\ 0\\.021594608105860752\ \(0\)\
\-\ iv\\:\\ 0\\.0215775582650593\ \(0\)\
\-\ nerve\\:\\ 0\\.021543622437359935\ \(0\)\
\-\ otherwise\\:\\ 0\\.021526735753207807\ \(0\)\
\-\ malignant\\:\\ 0\\.021526735753207807\ \(0\)\
\-\ status\\:\\ 0\\.021074536656314712\ \(0\)\
\-\ location\\:\\ 0\\.021028300807898526\ \(0\)\
\-\ labs\\:\\ 0\\.02092196209070408\ \(0\)\
\-\ does\\:\\ 0\\.020877034203009293\ \(0\)\
\-\ now\\:\\ 0\\.020729969996429985\ \(0\)\
\-\ left\\:\\ 0\\.020602895493846477\ \(0\)\
\-\ thickening\\:\\ 0\\.020544697729841178\ \(0\)\
\-\ recent\\:\\ 0\\.020447557921986357\ \(0\)\
\-\ inflammatory\\:\\ 0\\.020420127959102218\ \(0\)\
\-\ followed\\:\\ 0\\.0203928393884071\ \(0\)\
\-\ first\\:\\ 0\\.02037924767107493\ \(0\)\
\-\ week\\:\\ 0\\.020311807638130935\ \(0\)\
\-\ type\\:\\ 0\\.020258467428767604\ \(0\)\
\-\ central\\:\\ 0\\.020166396047334334\ \(0\)\
\-\ back\\:\\ 0\\.02014038139551141\ \(0\)\
\-\ right\\:\\ 0\\.020024261474734475\ \(0\)\
\-\ body\\:\\ 0\\.019874678343859174\ \(0\)\
\-\ several\\:\\ 0\\.01981333384525923\ \(0\)\
\-\ medial\\:\\ 0\\.019657087265018733\ \(0\)\
\-\ bowel\\:\\ 0\\.019380215232234897\ \(0\)\
\-\ diffuse\\:\\ 0\\.018938345838117536\ \(0\)\
\-\ yo\\:\\ 0\\.018866457639490866\ \(0\)\
\-\ only\\:\\ 0\\.018866457639490866\ \(0\)\
\-\ primary\\:\\ 0\\.018568965277658687\ \(0\)\
\-\ evaluation\\:\\ 0\\.018416883839615168\ \(0\)\
\-\ loss\\:\\ 0\\.018398177208868268\ \(0\)\
\-\ changes\\:\\ 0\\.01825085720546861\ \(0\)\
\-\ level\\:\\ 0\\.018241784416627684\ \(0\)\
\-\ on\\:\\ 0\\.0182410737153033\ \(0\)\
\-\ lymphoma\\:\\ 0\\.01798521765467093\ \(0\)\
\-\ however\\:\\ 0\\.01787412136963914\ \(0\)\
\-\ 10\\:\\ 0\\.017658687503822296\ \(0\)\
\-\ significant\\:\\ 0\\.01743608536084502\ \(0\)\
\-\ therapy\\:\\ 0\\.017351132872808837\ \(0\)\
\-\ high\\:\\ 0\\.017162983326866176\ \(0\)\
\-\ signal\\:\\ 0\\.017118805287520338\ \(0\)\
\-\ who\\:\\ 0\\.01708226980094407\ \(0\)\
\-\ bone\\:\\ 0\\.016477372015903796\ \(0\)\
\-\ soft\\:\\ 0\\.01607716483189624\ \(0\)\
\-\ associated\\:\\ 0\\.01591699887164155\ \(0\)\
\-\ can\\:\\ 0\\.015847340353565584\ \(0\)\
\-\ tissue\\:\\ 0\\.015841576639340365\ \(0\)\
\-\ woman\\:\\ 0\\.01572760084866623\ \(0\)\
\-\ most\\:\\ 0\\.015716337076346946\ \(0\)\
\-\ were\\:\\ 0\\.01556657620784902\ \(0\)\
\-\ present\\:\\ 0\\.0154959526639172\ \(0\)\
\-\ exam\\:\\ 0\\.015202059194808895\ \(0\)\
\-\ may\\:\\ 0\\.015196956571770065\ \(0\)\
\-\ have\\:\\ 0\\.015085925464963568\ \(0\)\
\-\ lateral\\:\\ 0\\.0149869698550011\ \(0\)\
\-\ findings\\:\\ 0\\.014904287874046497\ \(0\)\
\-\ contrast\\:\\ 0\\.014672949616134674\ \(0\)\
\-\ well\\:\\ 0\\.014622377211643067\ \(0\)\
\-\ presents\\:\\ 0\\.01452715118303905\ \(0\)\
\-\ treatment\\:\\ 0\\.014385260719930522\ \(0\)\
\-\ seen\\:\\ 0\\.014217320758212654\ \(0\)\
\-\ within\\:\\ 0\\.013908606935326997\ \(0\)\
\-\ from\\:\\ 0\\.011993657951718344\ \(0\)\
\-\ not\\:\\ 0\\.011921742924307826\ \(0\)\
